![Erik Sims](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Erik Sims
Corporate Officer/Principal presso OCUPHIRE PHARMA, INC.
Profilo
Erik Sims is currently working as the Senior Director-Finance at Ocuphire Pharma, Inc. He previously worked as the Assistant Controller at Gemphire Therapeutics, Inc. Mr. Sims holds an MBA from Walsh College and an undergraduate degree from the University of Michigan-Flint.
Posizioni attive di Erik Sims
Società | Posizione | Inizio |
---|---|---|
OCUPHIRE PHARMA, INC. | Corporate Officer/Principal | 01/06/2023 |
Precedenti posizioni note di Erik Sims
Società | Posizione | Fine |
---|---|---|
NEUROBO PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formazione di Erik Sims
Walsh College | Masters Business Admin |
University of Michigan-Flint | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
OCUPHIRE PHARMA, INC. | Health Technology |
Aziende private | 1 |
---|---|
Gemphire Therapeutics, Inc.
![]() Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand. The company was founded by Charles L. Bisgaier and David Lowenschuss on October 30, 2014 and is headquartered in Livonia, MI. | Health Technology |
- Borsa valori
- Insiders
- Erik Sims